The Glassware Core and its 24 staff members employ over 100 pieces of equipment, throughout the Rockefeller, Schwartz and Zuckerman Research Centers, to deliver more than 5,000 pieces of cleaned and sterilized labware to more than 110 investigators and their staff. Daily routines include decontamination and collection of soiled labware;hand-scrubbing and visual inspection of each piece before further processing in commercial glasswashers;sorting, wrapping, and/or plugging followed by processing in high-temperature ovens and steam autoclaves before return to the laboratories. Specialized procedures also provide for acidwashing and RNase-free preparations. All processing follows standardized operating procedures specially adapted to meet the needs of each user, and is ascertained to meet the minimum standard of "visually clean" or less than 4 ug/ml of debris, following the criteria for acceptance of LeBlanc and the FDA on the validation of cleaning processes. Over 90% of all work is restocked in each laboratory within an 8-hour time frame, providing cost and space savings to the laboratories. This core also provides dry ice stores throughout the research environment, assists with the monitoring of disposal of biohazardous waste and broken glass from laboratories, as well as provides for the decontamination of radioactive and other forms of biohazardous waste. To minimize costs to the laboratories, only "hands-on" time is charged for all services. Changes are anticipated in operating procedures to allow increased standardization in washing with the use of acid and alkaline detergents in the glasswashing machines, further reducing the "hands-on" time charged to users. When demand dictates, services will be expanded to include standardized cleaning of specialized laboratory equipment, such as cell and tissue incubators or freezers.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA008748-47S4
Application #
8602870
Study Section
Subcommittee G - Education (NCI)
Project Start
1997-01-20
Project End
2014-12-31
Budget Start
2012-01-09
Budget End
2012-12-31
Support Year
47
Fiscal Year
2013
Total Cost
$904,577
Indirect Cost
$427,480
Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065
Orlow, I; Satagopan, J M; Berwick, M et al. (2015) Genetic factors associated with naevus count and dermoscopic patterns: preliminary results from the Study of Nevi in Children (SONIC). Br J Dermatol 172:1081-9
Carey, Bryce W; Finley, Lydia W S; Cross, Justin R et al. (2015) Intracellular ?-ketoglutarate maintains the pluripotency of embryonic stem cells. Nature 518:413-6
Mosher, C E; Given, B A; Ostroff, J S (2015) Barriers to mental health service use among distressed family caregivers of lung cancer patients. Eur J Cancer Care (Engl) 24:50-9
Navi, Babak B; Reiner, Anne S; Kamel, Hooman et al. (2015) Association between incident cancer and subsequent stroke. Ann Neurol 77:291-300
Xu, Zhe; Wu, Chaochao; Xie, Fang et al. (2015) Comprehensive quantitative analysis of ovarian and breast cancer tumor peptidomes. J Proteome Res 14:422-33
Xu, Hong; Cheng, Ming; Guo, Hongfen et al. (2015) Retargeting T cells to GD2 pentasaccharide on human tumors using Bispecific humanized antibody. Cancer Immunol Res 3:266-77
Gondo, Tatsuo; Poon, Bing Ying; Matsumoto, Kazuhiro et al. (2015) Clinical role of pathological downgrading after radical prostatectomy in patients with biopsy confirmed Gleason score 3 + 4 prostate cancer. BJU Int 115:81-6
Ripley, R Taylor; McMillan, Robert R; Sima, Camelia S et al. (2014) Second primary lung cancers: smokers versus nonsmokers after resection of stage I lung adenocarcinoma. Ann Thorac Surg 98:968-74
Ye, Jiangbin; Fan, Jing; Venneti, Sriram et al. (2014) Serine catabolism regulates mitochondrial redox control during hypoxia. Cancer Discov 4:1406-17
Lu, Zhigang; Xu, Jin; Xu, Mingming et al. (2014) Morphine regulates expression of *-opioid receptor MOR-1A, an intron-retention carboxyl terminal splice variant of the *-opioid receptor (OPRM1) gene via miR-103/miR-107. Mol Pharmacol 85:368-80

Showing the most recent 10 out of 836 publications